Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/06/068779
CTRI/2024/06/068779
Not yet recruiting
未知

Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Adenocarcinoma of the Prostate - NI

Pfizer Products India Private Limited0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Pfizer Products India Private Limited
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Pfizer Products India Private Limited

Eligibility Criteria

Inclusion Criteria

  • •Patients diagnosed and/or treated with mCSPC or mCRPC 01 January 2023 onwards,
  • •inclusive. mCSPC is defined as the current and/or historical presence of metastases
  • •on any imaging modality sensitive to hormone therapy. mCRPC is defined as the
  • •current and/or historical presence of metastases on any imaging modality with
  • •evidence of disease progression (a rising PSA or radiographic progression (as defined
  • •by the investigator) despite ongoing castration therapy \[ADT or prior surgical
  • •orchiectomy]).1,9
  • •Aged at least 18 years upon diagnosis of mCSPC or mCRPC.

Exclusion Criteria

  • •Previously enrolled in an interventional trial related to metastatic prostate cancer.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Real world study of Bladder Cancer patients in India
CTRI/2024/06/068713Pfizer Products India Private Limited
Not yet recruiting
Not Applicable
Scientific data review of prostate cancer patients to study treatment patterns and understand need gaps.Health Condition 1: N428- Other specified disorders of prostate
CTRI/2024/08/072504Pfizer Limited
Completed
Not Applicable
Real World Treatment Patterns and Clinical Outcomes in Unfit AML Patients Receiving First Line Systemic Treatment or Best Supportive Care (CURRENT)Acute myeloid leukemia
JPRN-UMIN000037786AbbVie Inc.1,762
Not yet recruiting
Not Applicable
Real-world treatment patterns and clinical outcomes among patients with stage I-? non-small cell lung cancer in South Korea
KCT0006723Asan Medical Center4,000
Not yet recruiting
Not Applicable
Clinical presentation, Management, Treatment and Outcome of COVID patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/07/026510Hindu Mission Hospital